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Background: Intestinal obstruction is an abdominal disease associated to mortality, especially if
complicated with sepsis. Resuscitation increases survival, although controversies remain concerning to
therapeutic strategy.
Methods: To assess the effects of hypertonic saline and pentoxifylline on the inﬂammatory response and
oxidative stress, Wistar rats underwent a laparotomy loop intestinal obstruction and ischemia. After 24 h,
the intestinal segment was resected (IO) without any other treatment and resuscitation/pentoxifylline
were administered according to the group: Ringer’s lactate (RL); hypertonic saline (HS); pentoxifylline
(PTX); Ringer’s lactate with pentoxifylline (RL þ PTX); hypertonic saline with pentoxifylline (HS þ PTX)
and the control group (CG) that was not submitted to ischemia and obstruction. Mean arterial pressure
(MAP) was recorded 4 times, and euthanasia was done 3 h after the resuscitation to obtain lung tissue,
for malondialdehyde (MDA) by thiobarbituric acid reactive substances (TBARS) method, inﬂammatory
cytokines were assessed using ELISA and NF-kB by Western blotting.
Results: The initial MAP levels were higher in the RL and HS groups than in the others; however, the last
measurement was similar among all the groups. IL-1b, IL-6 and CINC-1 (Cytokine-Induced Neutrophil
Chemoattractant-1) were lower in the HS, PTX and HS þ PTX groups compared with the IO and RL
groups. IL-10 was lower in the HS þ PTX group than in the IO group. NF-kB in the HS, PTX and HS þ PTX
groups were lower than in the IO group; NF-kB in the HS þ PTX group was lower than in the RL group.
MDA in the lung was lower in the HS þ PTX group compared with other groups.
Conclusion: Hypertonic saline and pentoxifylline, both alone and in combination, attenuated oxidative
stress and the activation of NF-kB, leading to a decrease in the inﬂammatory response.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Intestinal obstruction is one of the most common acute
abdominal diseases, with high rates of complications and mortality
in the presence of intestinal necrosis. The inﬂammatory response is
believed to play an important role in the pathophysiology of acute
intestinal obstruction by activating polymorphonuclear leukocytes.
This process causes a release of inﬂammatory cytokines, reactiveOnze, 06540-395 Alphaville,
rassonsmontero@usp.br (E.F.
by Elsevier Ltd. All rights reservedoxygen species and nitric oxide [1]. Bacterial translocation is
considered to be a crucial factor in the pathogenesis of sepsis, and
this phenomenon is involved in intestinal obstruction associated
with ischemia [2e5].
The treatment of abdominal sepsis in patients with an intestinal
obstruction requires ﬂuid resuscitation, the early use of antibiotics,
the management of electrolyte and metabolic disorders and the
immediate removal of the obstructive factor [6,7]. Ringer’s lactate
(RL) is the most widely used crystalloid for resuscitation; even
leading to activation of the inﬂammatory response [8e10]. Because
of the deleterious effects of RL solution new solutions are being
studied for use in ﬂuid resuscitation during shock [11,12].
Hypertonic saline solution (HS) modulates the immune and
inﬂammatory responses [13] by inhibiting leukocyteeendothelial.
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addition, HS attenuates the phosphorylation of NF-kB, decreasing
the synthesis of cytokines [17].
The central role of the inﬂammatory response has stimulated
the search for strategies to treat abdominal sepsis that combine
pharmacologic therapy with resuscitation solutions. In this context,
pentoxifylline (PTX), which is derived from methylxanthine, im-
proves blood ﬂow in the microcirculation due to its hemorheo-
logical properties and decreases inﬂammatory activity by acting on
neutrophil activation and TNF-a production [18]. In fact, PTX has
been shown to diminish lung and liver injuries [19,20] and proin-
ﬂammatory cytokine levels [21] in experimental sepsis models.
Furthermore, using a combination of HS and PTX in an endotracheal
LPS injection sepsis model, Kim and Lee [22] demonstrated a low
production of TNF-a and IL-6.
Considering that the injection of toxins to induce sepsis repre-
sents amodel that is distant from the clinical setting and considering
the limited number of studies evaluating volume resuscitation in
severe intestinal obstruction, the aim of the present study was to
verify if 7.5% HS associated with PTX would attenuate the inﬂam-
matory response and oxidative stress associated with experimental
sepsis caused by intestinal obstruction and ischemia in rats.
2. Materials and methods
This study was approved by the Research Ethics Committee of
the School of Medicine e University of XXXXXX (Process number
172/11). The experiments were performed in adherence with the
International guidelines for the care and use of laboratory animals,
at the Laboratory of Surgical Physiopathology (LIM-62).
Male Wistar rats (250e300 g) were purchased from the
Department of Laboratory Animal Science of the School of Medi-
cine, University of XXXXXX. The rats were bred and maintained
under a 12-h light/dark cycle at a controlled temperature (23 C),
with free access to food and tap water.
2.1. Surgical procedures and experimental protocol
The rats were anesthetized by an intraperitoneal injection of
ketamine (50 mg/kg) and xylazine (10 mg/kg). A small (3 cm) mid-
abdominal incision was made, and the cecum and terminal ileum
were exposed. The closed loop intestinal obstruction was created
by the ligation of the ileum 10 cm and 1.5 cm from the ileocecal
valve using silk 4e0 thread. The mesenteric vessels that irrigated
the occluded segment were also ligated with silk 4e0 thread. Next,
the abdomen was closed with nylon 4e0 sutures, and the animals
were maintained in individual cages for 24-h, with free access to
tap water.
Twenty-four hours after the intestinal ischemia and obstruction,
the rats were again anesthetized with ketamine (50 mg/kg) and
xylazine (10 mg/kg) to cannulate the cervical vessels. A catheter
placed into the right carotid artery was connected to a pressure
transducer (Dixtal DX2020, Dixtal Biomédica-SP, Brazil) to measure
the mean arterial blood pressure (MAP), which was recorded at the
following times: after catheterization (T1) to obtain the initial
measurement and at 5 (T2), 30 (T3) and 45 (T4) min after resus-
citation. A catheter was placed into the right jugular vein for the
injection of drugs.
The animals were divided into experimental groups according
to resuscitation protocol, and each group contained six rats: IO
(Intestinal ischemia and obstruction); RL (32 mL/kg); HS (4 mL/kg);
PTX (25 mg/kg); RL (32 mL/kg) þ PTX (25 mg/kg); HS (4 mL/
kg) þ PTX (25 mg/kg). To obtain baseline values, a group of animals
were submitted to anesthesia and laparotomy (Control group e
CG). The drugs were infused over a 5 min period.The choice of 32mL/kg of RL and 4mL/kg of HSwas based on the
Naþ levels. The volume of each used solution adds a load of
5.12 mEq Naþ/kg body weight [23]. Regarding to pentoxifylline, we
used the dose of 25 mg/kg based on other studies about hemor-
rhagic and septic shock [21,24].
Immediately after the resuscitation (T1), all rats of the experi-
mental groups underwent a second mid-abdominal incision. The
necrotic intestinal segment was resected, intestinal anastomosis
was performed with polypropylene 6-0 sutures, and the abdomen
was closed with nylon 4-0 sutures. The mean duration of the pro-
cedure was about 45 min and during this period the blood pressure
was measured. Following the surgery, the animal recovered and
was kept in cages to complete 3 h after the resuscitation and then
euthanasia was performed. Samples of the lung were obtained for
the measurement of MDA, cytokines (IL-1b, IL-6, IL-10 and CINC-1)
and NF-kB levels.
2.2. MDA assay
We determined the cell membrane lipid peroxidation in the
pulmonary tissue caused by reactive oxygen species with the TBARS
method that measures the amount of MDA, which is expressed in
nanomoles per milligram of protein (nmol/mg protein), as described
previously [25]. The medial portion of the left lung was frozen
at 80 C, and a fragment was homogenized in 1 mL of 1.15% KCl
using a sonicator (Polytron PT-MR 3100, Kinematica AG, Lucerne,
Switzerland). Aliquots of the homogenized lung tissue were then
centrifuged at 10,000 rpm for 20 min at 4 C (5804 Centrifuge;
Eppendorf). The following were combined for the TBARS reaction:
100 mL of the supernatant, 100 mL of 8.1% sodium dodecyl sulfate
(SDS), 750 mL of 20% acetic acid and 750 mL of 0.8% thiobarbituric
acid. Themixturewas heated for 50min at 95 C. Subsequently, 200-
mL aliquots were analyzed in a spectrophotometer at 532 nm
(Multiscan Ex, MTX Lab Systems, Vienna, VA, USA). The results were
analyzed in duplicate and are expressed in mg/mg protein.
2.3. Western blot
The lungs were homogenized in phosphate-buffered saline
(PBS) containing 1% Protease Inhibitor Cocktail (Sigma Chemical
Co.) according to the manufacturer’s instructions. Samples con-
taining 37.5 mg of protein were separated by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE, 10%) and transferred to a nitrocel-
lulose membrane (Invitrogen, Carlsbad, CA, USA). The membranes
were incubated for 60 min in TSB-T (150 mM NaCl, 20 mM Tris and
1% Tween 20, pH 7.4) containing 5% nonfat dried milk. The blots
were then washed with TSB-T and probed with antibodies against
Phospho-NF-kB p65 e Ser536 (Cell Signaling Technology, Inc., MA,
USA) for 120 min at room temperature. The membranes were
washed with TBS-T and incubated with peroxidase-conjugated
monoclonal anti-rabbit IgG (Cell Signaling Technology, Inc., MA,
USA) for 60 min at room temperature. The immunocomplexed
peroxidase-labeled antibodies were visualized with an enhanced
chemiluminescence (ECL) kit according to the manufacturer’s in-
structions (Amersham, Piscataway, NJ, USA) and were exposed to
photographic ﬁlm. Finally, the blots were stripped and reprobed
with b-actin. The band densities were determined by densitometry
analysis using the AlphaEaseFC program. The density values of
the bands were normalized to the total b-actin present in each lane
and were expressed as a percentage of the control.
2.4. Cytokine assays
Samples of lung homogenate were quantiﬁed and the concen-
trations of IL-6, IL-1b, IL-10 and CINC-1 were determined by ELISA
Fig. 1. Effects of the therapeutic strategy on MAP (mmHg). Male Wistar rats under-
went intestinal resection and treatment with the following: no resuscitation (IO),
Ringer’s lactate (RL), hypertonic saline (HS), pentoxifylline (PTX), RL þ PTX or
HS þ PTX. The data are expressed as the medians. T1-immediately after cervical
cannulation; T2-5 min after resuscitation; T3-30 min after resuscitation; T4-45 min
after resuscitation. * versus IO; ** versus RL; p versus HS; # versus PTX; U versus
RL þ PTX; & versus HS þ PTX.
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instructions (R & D Systems Inc., Minneapolis, MN, USA), as
described before [25]. The assays were performed in triplicate.
2.5. Statistical analysis
The calculation of an appropriate sample size was performed
using Altman normogram as described by Whitley and Ball (2002).
Considering 80% of level of statistic power and P-value  0.05, we
used the difference of IL-6 expression in lungs between reference
and maximal lesion groups of a previously study [25]. Sample size
estimated was 4e5 animals per group.
The data were analyzed using the SigmaStat e version 3.1
(Systat Software, San Diego, CA, USA). Data are expressed as
mean standard error (SEM). Analysis of variance (Anova on ranks)
was used to compare groups and post-hoc tests were performed
when necessary (StudenteNewmaneKeuls or Dunn’s test).
3. Results
3.1. Hemodynamic variables
For the ﬁrst MAP (expressed in mmHg) measurement (T1),
which was performed immediately after the cervical catheteriza-
tion, there were no differences among the groups (IO, 75  12; RL,
77  7; HS, 85  6; PTX, 79  9; RL þ PTX, 72  5; HS þ PTX,
81  15).
After 5 min of resuscitation (T2), the RL (94  12) and HS
(131  16) groups exhibited increased MAP levels compared with
the other groups (IO, 81  7; PTX, 77  13; RL þ PTX, 77  7;
HS þ PTX, 85  13), and the level of the HS group was higher than
that of the RL group.
For the third blood pressure measurement (T3), which was
performed after 30 min of resuscitation, HS þ PTX (92  12)
showed an increasing MAP value compared with the other groups,
except for PTX (IO, 75  9; RL, 71  11; HS, 80  5; PTX, 86  6;
RL þ PTX, 74  15). The PTX group exhibited a higher level than the
IO and RL groups. The HS group had a higher level than the RL
group.
At the end of the procedure, after 45min of resuscitation (T4), all
the groups had similar MAP values (IO, 78  6; RL, 73  10; HS,
81  6; PTX, 78  14; RL þ PTX, 75  7; HS þ PTX, 86  13) (Fig. 1).
All data related to MDA, cytokines, and NFkB are summarized at
Table 1.
3.2. MDA levels
Lipidic peroxydation was attenuated by pentoxifylline associ-
ated to hypertonic solution. As shown in Fig. 2, the MDA levels
(nmol/mg of protein) in the lung after the HS þ PTX (0.30  0.01)
treatment were signiﬁcantly lower than those in the other groups
(IO, 0.49  0.06; RL, 0.50  0.09; HS, 0.51  0.07; PTX, 0.44  0.03;
RL þ PTX, 0.49  0.05). The control value (CG) was 0.018  0.003.
3.3. Cytokine levels (IL-1b, IL-6, IL-10 and CINC-1)
The animals that received HS (1.05 0.17 ng/mg of protein), PTX
(0.59  0.09 ng/mg of protein) and HS þ PTX (0.61  0.03 ng/mg of
protein) had signiﬁcantly decreased IL-6 levels compared with the
IO (2.04  0.26 ng/mg of protein) and RL (2.08  0.18 ng/mg of
protein) animals. The increase in the IL-6 levels caused by IO was
not attenuated by RL, even when PTX was added to RL
(1.50  0.16 ng/mg of protein; p > 0.05). The PTX and HS þ PTX
groups had lower IL-6 levels compared with the HS group (Fig. 3a).
The control value (CG) was 0.40  0.016 (ng/mg of protein).The CINC-1 levels were decreased in all the treated groups (RL,
0.64  0.02; HS, 0.51  0.04; PTX, 0.49  0.03; RL þ PTX,
0.54  0.02; HS þ PTX, 0.42  0.01 ng/mg of protein) compared
with the IO group (0.76  0.06 ng/mg of protein). The animals that
received RL showed elevated levels of CINC-1 compared with the
other groups that underwent volume resuscitation. Although the
HS þ PTX group had lower CINC-1 levels than the HS, PTX and
RL þ PTX groups, these differences were not signiﬁcant (Fig. 3b).
The control value (CG) was 0.11  0.02 ng/mg of protein.
The IL-1b levels decreased in the HS (1.40  0.10 ng/mg of
protein), PTX (1.58  0.13 ng/mg of protein) and HS þ PTX
(1.66  0.05 ng/mg of protein) groups compared with the IO
(2.40  0.18 ng/mg of protein) and RL (2.06  0.21 ng/mg of pro-
tein) groups, and after the addition of PTX to the RL (2.42 0.22 ng/
mg of protein) (Fig. 3c). The control value (CG) was 0.44  0.08 ng/
mg of protein.
The IL-10 level following the HS þ PTX (0.07  0.01 ng/mg of
protein) treatment was signiﬁcantly lower than that in the IO
(0.47  0.15 ng/mg of protein) group. Although the HS þ PTX
treatment decreased the IL-10 levels compared with the RL treat-
ment (0.36 0.11 ng/mg of protein), this changewas not signiﬁcant
(Fig. 3d). The control value (CG) was 0.029  0.0013 ng/mg of
protein.
3.4. NF-kB phosphorylation
The animals that received HS, PTX and HS þ PTX had signiﬁcant
reduction in lung NF-kB phosphorylation compared with the IO
group. HS þ PTX was the only treatment associated with a lower
level of NF-kB phosphorylation compared with the RL treatment
(Fig. 4). Relative to IO groups, treatment of the animals with HS, PTX
and HS þ PTX signiﬁcantly reduced NF-kB phosphorylation (78%,
73% and 84%, respectively). The IO group increased 81% of NF-kB
phosphorylation compared to. Control group (CG).
4. Discussion
A therapeutic strategy involving the co-administration of HS
and PTX was used to successfully treat abdominal sepsis. This
Table 1
Inﬂammatory mediator.
Group MDA (nmol/mg of protein) IL-6 (ng/ml) CINC-1 (ng/ml) IL-1b (ng/ml) IL-10 (ng/ml) NF-kB
(arbitrary units x103)
CG 0.018  0.003 0.40  0.016 0.11  0.02 0.44  0.08 0.029  0.0013 54  4
IO 0.49  0.06 2.04  0.26 0.76  0.06 2.40  0.18 0.47  0.15 286  33
RL 0.50  0.09 2.08  0.18 0.64  0.02a 2.06  0.21 0.36  0.11 121  16
HS 0.51  0.07 1.05  0.17a,b,d 0.51  0.04a,b 1.40  0.10a,b,d 0.19  0.04 64  10a
PTX 0.44  0.03 0.59  0.09a,b,c,d 0.49  0.03a,b 1.58  0.13a,b,d 0.12  0.05 79  7a
RL þ PTX 0.49  0.05 1.50  0.16 0.54  0.02a,b 2.42  0.22 0.20  0.04 93  6
HS þ PTX 0.30  0.01a,b,c,d,e 0.61  0.03a,b,c,d 0.42  0.01a,b 1.66  0.05a,b,d 0.07  0.01a 47  6a,b
Control Group (CG); No resuscitation (IO), Ringer’s lactate (RL), hypertonic saline (HS), pentoxifylline (PTX), RL þ PTX or HS þ PTX. Data are presented as mean  SEM for 6
animals in each group. ap < 0.05 versus IO; bp < 0.05 versus RL; cp < 0.05 versus SH; dp < 0.05 versus RL þ PTX; ep < 0.05 versus PTX.
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culminated in the reduced expression of inﬂammatory cytokines. In
addition, we showed that the HS þ PTX treatment reduced oxida-
tive stress in the animals. The beneﬁts of HS alone were improved
by administering it in combination with PTX, an effect that was
most likely due to the anti-inﬂammatory properties of PTX.
Although PTX alone produced similar results to those of HS þ PTX,
patients with intestinal obstruction and sepsis require ﬂuid resus-
citation. Studies that have evaluated HS þ PTX combinations
generally have not assessed the effect of each treatment alone, as
we did in this study.
This model represents a strangulation small bowel obstruction,
a cause of abdominal sepsis, a common problem in emergency
department. Themortality rate among these patients is around 16%,
despite the advances in the care of the critically ill patient. Intes-
tinal obstruction is associated with ﬂuid retention into the bowel
lumen and bowel wall. This ﬂuid retention causes hypovolemia andFig. 2. Effects of the therapeutic strategy on oxidative stress, as indicated by the MDA
concentrations (nmol/mg of protein) in the lung. Male Wistar rats underwent intes-
tinal resection and were treated with the following: no resuscitation (IO), Ringer’s
lactate (RL), hypertonic saline (HS), pentoxifylline (PTX), RL þ PTX or HS þ PTX. The
data are expressed as the medians (interquartile range). * versus IO; ** versus RL; p
versus HS; # versus PTX; U versus RL þ PTX.requires ﬂuid resuscitation [26]. We believe that our results of the
ﬁrst analysis of the MAP (24 h after the intestinal obstruction and
ischemia) represent a state of hypotension in rats. Shih et al. [27] in
a cecal ligation and puncture model demonstrated MAP levels 18 h
after the peritonitis similar to our data.
Fevang et al. [26] demonstrated that the ﬂuid resuscitation
improves intestinal blood ﬂow and reduces the mucosal damage
associated with strangulation obstruction. In some situations the
use of large amount of ﬂuids causes intra abdominal hypertension.
Experimental studies have shown that HS decreased oxidative
stress, the inﬂammatory response, bacterial translocation and
mortality in a sepsis model, although HS is rarely used in clinical
practice [15,17,27]. A recent clinical trial in which HS was admin-
istered to septic patients produced improvements in the patients’
cardiovascular parameters but did not provide microcirculatory
beneﬁts [28].
The application of the HS þ PTX treatment strategy to hemor-
rhagic shock cases has been widely studied [24,29,30], but this
strategy has only been applied to treat sepsis in one recent exper-
imental study [22]. Kim and Lee [22] used the endotracheal injec-
tion of LPS to create a more aggressive sepsis model than ours; the
sepsis induced by intestinal obstruction and ischemia in our model
was secondary to bacterial translocation [3e5]. Endotoxemia
models that exhibit sudden increases in the levels of proin-
ﬂammatory cytokines [31] differ from our model, which demon-
strated a slow augmentation of inﬂammatory activity similar to the
pathophysiology of sepsis in human patients.
The pathogenesis of sepsis is a dynamic and complex process
due to the unique timing of the transition from inﬂammation to
immune suppression in each patient. Therefore, immune system
modulation may represent a better therapeutic strategy than the
complete inhibition of inﬂammatory mediators [32,33].
In the present study, HS, PTX and the HS þ PTX combination
reduced the levels of IL-1b, IL-6 and CINC-1. However, the admin-
istration of RL (evenwhen combined with PTX) increased the levels
of these proinﬂammatory cytokines, except for CINC-1, thereby
promoting inﬂammatory activity. Both HS and PTX were able to
reduce the levels of proinﬂammatory cytokines but did not
completely inhibit their activity, corroborating recent studies that
showed reduced inﬂammatory responses in sepsis models
[17,22,34].
We found that HS þ PTX treatment signiﬁcantly decreased the
levels of IL-10. In an analysis of intensive care patients, Gogos et al.
[35] found that elevated levels of TNF-a and IL-10 were associated
with elevatedmortality, which increased evenmorewhen the IL-10
level was higher than that of TNF-a. The authors concluded that the
persistence of strong IL-10 synthesis was the main predictor of
mortality in the intensive care unit. Muenzer et al. [36] studied the
effects of blocking IL-10 in a peritonitis model followed by pneu-
monia and showed an improvement in survival due to an increase
Fig. 3. Effects of the therapeutic strategy on inﬂammatory proﬁles, as indicated by the concentrations (ng/mg of protein) in the lung of the following cytokines: IL-6 (a), CINC-1 (b),
IL-1b (c) and IL-10 (d). Male Wistar rats underwent intestinal resection and were treated with the following: no resuscitation (IO), Ringer’s lactate (RL), hypertonic saline (HS),
pentoxifylline (PTX), RL þ PTX or HS þ PTX. The data are expressed as the medians (interquartile range). * versus IO; ** versus RL; p versus HS; U versus RL þ PTX.
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bloodstream. HS has been shown to reduce the levels of IL-10 in an
endotoxemia model of sepsis [17].
Thus, the strategy of attenuating the initial immune response
with a decrease in the synthesis of proinﬂammatory cytokines
may result in reduced activation of anti-inﬂammatory cytokines.
This phenomenon was evidenced in the present study by the low
production of proinﬂammatory cytokines and IL-10 in the
HS þ PTX group. Thus, these data conﬁrm the importance of un-
derstanding the balance between pro- and anti-inﬂammatory
properties and their relationships with the phase of the immune
response.
The mechanism responsible for the decreased synthesis of
proinﬂammatory cytokines is directly related to NF-kB activationand extracellular stimuli, such as lipopolysaccharides, reactive ox-
ygen species and other cytotoxic agents, including the inﬂamma-
tory cytokines [37].
Arnalich et al. [38] assessed the activity of NF-kB in patients with
severe sepsis and revealed that levels of this protein were higher in
patients who had high severity scores or who died. That study
demonstrated that NF-kB is also a predictor of mortality. Similar
ﬁndings have been reported in cases of systemic inﬂammatory
response syndrome [39]. In animals experiencing hemorrhagic
shock, the administration of HS þ PTX has been associated with a
lower production of NF-kB compared with RL administration
[24,30,40].
The present study demonstrated that the animals treated with
HS, PTX or HS þ PTX exhibited attenuated NF-kB activation
Fig. 4. Effects of the therapeutic strategy on NF-kB phosphorylation. Male Wistar rats
underwent intestinal resection and were treated with the following: no resuscitation
(IO), Ringer’s lactate (RL), hypertonic saline (HS), pentoxifylline (PTX), RL þ PTX or
HS þ PTX. (A) a Western blot of phosphorylated NF-kB in pulmonary nuclear extracts.
(B) a Western blot gel of b actin of NF-kB. The images show 3 representative animals
from each experimental group. (C) The data are expressed as the medians (inter-
quartile range) * versus IO; ** versus RL.
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reduced the expression of this protein, but the outcomewas similar
to that in the untreated animals. HS þ PTX was the only strategy
that was superior to RL, which conﬁrms the synergistic relationship
between these drugs in the control of inﬂammatory activity.
Lipid peroxidation is a reaction between free radicals and un-
saturated lipids in the cell membrane that leads to the destruction
of the membrane structure and the depletion of ion exchange
factors, resulting in extreme conditions and cell death. The loss of
integrity in the intestinal mucosa is an effect of the damage caused
by oxygen free radicals [41]. In this study, HS þ PTX treatment
reduced the levels of MDA in the lung, producing a similar effect to
that observed in a model of trauma [42]. Neither PTX nor HS alone
signiﬁcantly reduced the oxidative stress in the lung.
There are some limitations to our experimental model and
protocol. Our model included a second step that induced additional
trauma in the septic animal. This trauma had a relevant effect; there
was a 46%mortality ratewithin the ﬁrst 24 h in thismodel (data not
shown). The short observation time following the treatment did not
allow an appropriate analysis of the impact of the treatment over a
longer period. Other end time points following the resuscitation
must be done to compare the early versus late inﬂammatory
response. The survival analysis after the treatment is an important
outcome that must be study, and will demonstrate the impact of
modulation of the inﬂammatory response.
Despite we do not have systemic cytokine measurement, we
believe that the increase in lung cytokine levels reﬂects a distance
inﬂammatory response related to the intestinal insult (primary
insult). Maybe, it would represent a multiple organ dysfunctionsyndrome, but it is necessary to show dysfunction in other organs.
On the other hand, it would be an acute lung injury, or its more
severe form, but it should be conﬁrmed by hypoxemic respiratory
failure. Other projects are ongoing to evaluate other organs, besides
biochemical and gasometric measurements. The lack of monitora-
tion the lactate and acid base balance throughout the 3 h after
treatment is one limitation to analyze the effectiveness of the
treatment.
As future directions, it is important to develop therapeutic
strategies that modulate the inﬂammatory response in intestinal
obstruction complicated with ischemia. Speciﬁc target inhibition of
the NF-kB, TLR-4 and cytokines can be done and compared the
effects of the treatment proposed in this paper.
In conclusion, treatment with a combination of HS and PTX
constitutes a resuscitation strategy based on a decrease in ﬂuid
volume combined with the modulation of the inﬂammatory
response, which decreases the oxidative stress and inﬂammatory
activity. Although the treatment with PTX alone produced similar
results to the HS þ PTX treatment, in the clinical setting, treating
patients in complicated intestinal obstruction is not feasible
without the restoration of hemodynamic parameters.
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